Report
Michael B. Schäfer

Symrise : Organic sales growth of 8.3% in Q3 in line, on the back of strong F&N, estimates for sales growth raised to 9% in line with the consensus

>Organic sales growth of 8.3% in Q3, in line with the consensus - Symrise has reported group sales of € 975m in Q3 21, largely in line with the consensus of € 963m (ODDO: € 942m) and up 10.6% y-o-y. Organic growth of 8.3% y-o-y was in line with the consensus estimate of 8.3% (ODDO BHF 7.8%) and slightly ahead of Givaudan's (not covered) reported 8.0% l-f-l sales growth in Q3 21. S&C growth below expectations, another strong F&N quarter (9.7%) - S&C sa...
Underlying
Symrise AG

Symrise AG develops, produces, and sells fragrances and flavors as well as active ingredients for the cosmetics industry. Co. operates in two main business segments: The Scent & Care segment, which develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances; and The Flavor & Nutrition segment, which develops, produces and sells flavors that are used by customers in the production of food products (savory and sweet food products as well as dairy products) and beverages.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Michael B. Schäfer

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch